Lung cancer drug sotorasib tested in chinese patients
NCT ID NCT07143513
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 39 times
Summary
This completed study looked at how safe sotorasib is for Chinese patients with a certain type of advanced lung cancer (KRAS G12C-mutated NSCLC). 102 patients who had already tried other treatments took sotorasib pills daily. Researchers tracked side effects and how long patients lived. The goal was to understand the drug's safety in a real-world setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boao Evergrande International Hospital
Qionghai, Hainan, 571400, China
-
Boao Super Hospital
Qionghai, Hainan, 571499, China
-
Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine Hainan Boao Research Hospital
Qionghai, Hainan, 57400, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sotorasib (a targeted cancer pill)
What this could lead to
If results are positive, this could confirm that sotorasib is safe and effective for Chinese patients with a specific type of lung cancer, supporting its use in this population.
What could go wrong
This is a completed real-world study, not a controlled trial, so results may be less reliable. Side effects like liver or lung problems are possible, and the drug only works for patients with a specific gene mutation.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.